M+ group A streptococci are phagocytized and killed in whole blood by C5a-activated polymorphonuclear leukocytes

被引:18
作者
DeMaster, E
Schnitzler, N
Cheng, Q
Cleary, P [1 ]
机构
[1] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA
[2] Univ Hosp, Natl Reference Lab Streptococci, Aachen, Germany
[3] Univ Hosp, Inst Med Microbiol, Aachen, Germany
关键词
D O I
10.1128/IAI.70.1.350-359.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Historically, resistance to phagocytosis has been determined by incubating group A streptococci in human blood and comparing the numbers of CFU before and after incubation. Utilizing a flow cytometry-based technique, we have investigated the phagocytosis of M+ group A streptococci by polymorphonuclear leukocytes (PMNs) in heparinized human peripheral whole blood. Intracellular labeling of streptococci with a nontoxic fluorescent dye allowed us to quantify the association and phagocytosis of M+ streptococci by PMNs in whole blood in the presence or absence of C5a, a physiologically important chemotactic activator of PMNs. We found that wild-type strains of group A streptococci that are resistant to phagocytosis (determined by the classical Lancefield method) readily associate with C5a-activated whole-blood PMNs. In the absence of opsonizing M-type-specific antibodies, the M+ streptococci associated with PMNs are phagocytized and killed. In addition, blockade of the beta (2) integrin, CD11b/CD18, with anti-human CD11b monoclonal antibody inhibited association between M+ streptococci and C5a-activated PMNs. These findings establish a new relationship between M+ streptococci and PMNs, in which C5a-activated PMNs have the capacity to kill M+ streptococci in whole blood through a receptor-mediated phagocytic mechanism.
引用
收藏
页码:350 / 359
页数:10
相关论文
共 25 条
[21]   A co-stimulatory signal through ICAM-β2 integrin-binding potentiates neutrophil phagocytosis [J].
Schnitzler, N ;
Haase, G ;
Podbielski, A ;
Lütticken, R ;
Schweizer, KG .
NATURE MEDICINE, 1999, 5 (02) :231-235
[22]  
SCHNITZLER N, 1997, ADV EXP MED BIOL, V418, P892
[23]  
SCHNITZLER N, 1995, MED MICROBIOL IMMUN, V18, P417
[24]  
SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P699
[25]   Cooperation between CR1 (CD35) and CR3 (CD11b/CD18) in the binding of complement-opsonized particles [J].
Sutterwala, FS ;
Rosenthal, LA ;
Mosser, DM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (06) :883-890